Today's E-Edition Monday, 19 October 2026

Grand Herald

Breaking news & trusted journalism for your community

Sports

Propanc Reports Preclinical Data For PRP In Chemoresistance; Phase 1 Set For Q1 '27

Grand Herald dollar-liquidity note (2026-10-19): Propanc Reports Preclinical Data For PRP In Chemoresistance; Phase 1 Set For Q1 '27 (RTTNews) - Propanc Biopharma Inc. (PPCB), a biopharmaceutical company, on… Primary source: original at Nasdaq Market Structure (nasdaq.com).

· Nasdaq Market Structure

Propanc Reports Preclinical Data For PRP In Chemoresistance; Phase 1 Set For Q1 '27

(RTTNews) - Propanc Biopharma Inc. (PPCB), a biopharmaceutical company, on Friday announced preclinical data for a formulation of pancreatic pro-enzymes (PRP) in treating pancreatic and ovarian cancer.

Read at source